

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fibril organization (GO:0097435) | 9.67254816 |
| 2 | * digestion (GO:0007586) | 9.40602495 |
| 3 | glutathione derivative metabolic process (GO:1901685) | 9.06994036 |
| 4 | glutathione derivative biosynthetic process (GO:1901687) | 9.06994036 |
| 5 | O-glycan processing (GO:0016266) | 8.86761908 |
| 6 | sulfation (GO:0051923) | 8.38321612 |
| 7 | protein autoprocessing (GO:0016540) | 8.16808197 |
| 8 | * maintenance of gastrointestinal epithelium (GO:0030277) | 7.89075560 |
| 9 | hepatocyte apoptotic process (GO:0097284) | 7.53373276 |
| 10 | positive regulation of keratinocyte differentiation (GO:0045618) | 7.49476659 |
| 11 | regulation of proton transport (GO:0010155) | 7.47935780 |
| 12 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 7.11450556 |
| 13 | negative regulation of digestive system process (GO:0060457) | 6.86640839 |
| 14 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 6.82435442 |
| 15 | glandular epithelial cell differentiation (GO:0002067) | 6.72351337 |
| 16 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 6.70644357 |
| 17 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 6.70644357 |
| 18 | protein O-linked glycosylation (GO:0006493) | 6.33741777 |
| 19 | kidney morphogenesis (GO:0060993) | 6.21300842 |
| 20 | * epithelial structure maintenance (GO:0010669) | 5.96734321 |
| 21 | * digestive system process (GO:0022600) | 5.77262447 |
| 22 | ear development (GO:0043583) | 5.58884164 |
| 23 | production of molecular mediator of immune response (GO:0002440) | 5.56397200 |
| 24 | fucose catabolic process (GO:0019317) | 5.50994767 |
| 25 | L-fucose metabolic process (GO:0042354) | 5.50994767 |
| 26 | L-fucose catabolic process (GO:0042355) | 5.50994767 |
| 27 | regulation of phospholipase A2 activity (GO:0032429) | 5.50447039 |
| 28 | positive regulation of epidermal cell differentiation (GO:0045606) | 5.44692503 |
| 29 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 5.34760784 |
| 30 | thyroid hormone metabolic process (GO:0042403) | 5.29863435 |
| 31 | regulation of cell proliferation involved in kidney development (GO:1901722) | 5.20900390 |
| 32 | intestinal absorption (GO:0050892) | 5.13777584 |
| 33 | sulfur amino acid catabolic process (GO:0000098) | 4.95362959 |
| 34 | thyroid hormone generation (GO:0006590) | 4.94903472 |
| 35 | COPI coating of Golgi vesicle (GO:0048205) | 4.91499011 |
| 36 | Golgi transport vesicle coating (GO:0048200) | 4.91499011 |
| 37 | glutathione metabolic process (GO:0006749) | 4.77655863 |
| 38 | vagina development (GO:0060068) | 4.71395878 |
| 39 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.61854936 |
| 40 | phospholipid scrambling (GO:0017121) | 4.57543311 |
| 41 | regulation of keratinocyte differentiation (GO:0045616) | 4.57158821 |
| 42 | glucose 6-phosphate metabolic process (GO:0051156) | 4.45709750 |
| 43 | regulation of pH (GO:0006885) | 4.41135508 |
| 44 | xenobiotic metabolic process (GO:0006805) | 4.30311773 |
| 45 | maternal placenta development (GO:0001893) | 4.29060074 |
| 46 | embryonic camera-type eye morphogenesis (GO:0048596) | 4.28206400 |
| 47 | striated muscle atrophy (GO:0014891) | 4.27759033 |
| 48 | cell differentiation involved in embryonic placenta development (GO:0060706) | 4.27552682 |
| 49 | embryonic eye morphogenesis (GO:0048048) | 4.22950056 |
| 50 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.22879900 |
| 51 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.15750807 |
| 52 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.14667726 |
| 53 | face development (GO:0060324) | 4.13209010 |
| 54 | negative regulation of cell size (GO:0045792) | 4.11871214 |
| 55 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.10028043 |
| 56 | norepinephrine metabolic process (GO:0042415) | 4.08249413 |
| 57 | receptor recycling (GO:0001881) | 4.03818450 |
| 58 | phosphatidylserine metabolic process (GO:0006658) | 4.02527860 |
| 59 | pH reduction (GO:0045851) | 4.01639852 |
| 60 | regulation of centriole replication (GO:0046599) | 4.00988252 |
| 61 | amyloid precursor protein catabolic process (GO:0042987) | 4.00785649 |
| 62 | leukotriene metabolic process (GO:0006691) | 4.00363461 |
| 63 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.96459826 |
| 64 | nitric oxide biosynthetic process (GO:0006809) | 3.94759470 |
| 65 | response to food (GO:0032094) | 3.94504982 |
| 66 | cardiac right ventricle morphogenesis (GO:0003215) | 3.91573133 |
| 67 | GDP-mannose metabolic process (GO:0019673) | 3.87978569 |
| 68 | proline biosynthetic process (GO:0006561) | 3.87859585 |
| 69 | diacylglycerol metabolic process (GO:0046339) | 3.83688438 |
| 70 | mesonephros development (GO:0001823) | 3.81055560 |
| 71 | lung secretory cell differentiation (GO:0061140) | 3.79393097 |
| 72 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.78588803 |
| 73 | skeletal muscle adaptation (GO:0043501) | 3.78563034 |
| 74 | regulation of water loss via skin (GO:0033561) | 3.75259496 |
| 75 | cyclooxygenase pathway (GO:0019371) | 3.74187840 |
| 76 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.73904882 |
| 77 | cellular response to gonadotropin stimulus (GO:0071371) | 3.73762783 |
| 78 | negative regulation of organelle assembly (GO:1902116) | 3.73232550 |
| 79 | leukotriene biosynthetic process (GO:0019370) | 3.71364526 |
| 80 | cellular response to arsenic-containing substance (GO:0071243) | 3.64587887 |
| 81 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.61673175 |
| 82 | epithelial cell maturation (GO:0002070) | 3.61558559 |
| 83 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.61467514 |
| 84 | ethanol oxidation (GO:0006069) | 3.61362848 |
| 85 | post-embryonic morphogenesis (GO:0009886) | 3.61257893 |
| 86 | positive regulation of epidermis development (GO:0045684) | 3.61236128 |
| 87 | removal of superoxide radicals (GO:0019430) | 3.61179445 |
| 88 | cellular response to superoxide (GO:0071451) | 3.61179445 |
| 89 | cellular response to oxygen radical (GO:0071450) | 3.61179445 |
| 90 | muscle atrophy (GO:0014889) | 3.59231625 |
| 91 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.54158399 |
| 92 | acrosome reaction (GO:0007340) | 3.53795686 |
| 93 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.53206636 |
| 94 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.52939239 |
| 95 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.50698755 |
| 96 | regulation of interleukin-13 production (GO:0032656) | 3.43785917 |
| 97 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.41870309 |
| 98 | cellular zinc ion homeostasis (GO:0006882) | 3.41534113 |
| 99 | intestinal epithelial cell development (GO:0060576) | 3.41371007 |
| 100 | neutrophil mediated immunity (GO:0002446) | 3.39151633 |
| 101 | viral mRNA export from host cell nucleus (GO:0046784) | 3.38592517 |
| 102 | peptidyl-arginine methylation (GO:0018216) | 3.38536253 |
| 103 | peptidyl-arginine N-methylation (GO:0035246) | 3.38536253 |
| 104 | positive regulation of translational initiation (GO:0045948) | 3.36766024 |
| 105 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.35987271 |
| 106 | protein retention in ER lumen (GO:0006621) | 3.35961952 |
| 107 | regulation of establishment of cell polarity (GO:2000114) | 3.35343439 |
| 108 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.34425823 |
| 109 | alditol phosphate metabolic process (GO:0052646) | 3.34416981 |
| 110 | acid secretion (GO:0046717) | 3.32849252 |
| 111 | female genitalia development (GO:0030540) | 3.32700508 |
| 112 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.31827072 |
| 113 | L-serine transport (GO:0015825) | 3.31358719 |
| 114 | response to water (GO:0009415) | 3.29656813 |
| 115 | atrioventricular valve morphogenesis (GO:0003181) | 3.28671495 |
| 116 | columnar/cuboidal epithelial cell differentiation (GO:0002065) | 3.27682320 |
| 117 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.26945038 |
| 118 | regulation of histone H3-K27 methylation (GO:0061085) | 3.26911723 |
| 119 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 3.24814170 |
| 120 | nucleoside bisphosphate metabolic process (GO:0033865) | 3.24814170 |
| 121 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 3.24814170 |
| 122 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.23937885 |
| 123 | uterus development (GO:0060065) | 3.23539516 |
| 124 | negative regulation of kidney development (GO:0090185) | 3.21228416 |
| 125 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.19116008 |
| 126 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.18313730 |
| 127 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.18120333 |
| 128 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.18028479 |
| 129 | cell proliferation involved in metanephros development (GO:0072203) | 3.17919878 |
| 130 | cellular response to estrogen stimulus (GO:0071391) | 3.17793559 |
| 131 | regulation of macrophage activation (GO:0043030) | 3.17560890 |
| 132 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.17182891 |
| 133 | response to superoxide (GO:0000303) | 3.16497394 |
| 134 | fucose metabolic process (GO:0006004) | 3.13870507 |
| 135 | fatty acid derivative transport (GO:1901571) | 3.13355201 |
| 136 | icosanoid transport (GO:0071715) | 3.13355201 |
| 137 | sodium ion export (GO:0071436) | 3.12333996 |
| 138 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.11262391 |
| 139 | cobalamin metabolic process (GO:0009235) | 3.11163855 |
| 140 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.06613044 |
| 141 | outflow tract septum morphogenesis (GO:0003148) | 3.06456585 |
| 142 | growth hormone secretion (GO:0030252) | 3.05236887 |
| 143 | phosphate ion homeostasis (GO:0055062) | 3.05206903 |
| 144 | trivalent inorganic anion homeostasis (GO:0072506) | 3.05206903 |
| 145 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.03705653 |
| 146 | exocrine pancreas development (GO:0031017) | 3.03133088 |
| 147 | flavonoid metabolic process (GO:0009812) | 3.02448313 |
| 148 | cardiac conduction (GO:0061337) | 3.02413688 |
| 149 | histone arginine methylation (GO:0034969) | 3.02195076 |
| 150 | tight junction assembly (GO:0070830) | 3.01657570 |
| 151 | arachidonic acid secretion (GO:0050482) | 3.00890933 |
| 152 | icosanoid secretion (GO:0032309) | 3.00890933 |
| 153 | pentose-phosphate shunt (GO:0006098) | 3.00278509 |
| 154 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 3.00265501 |
| 155 | cell communication involved in cardiac conduction (GO:0086065) | 3.00110632 |
| 156 | biotin metabolic process (GO:0006768) | 2.97087679 |
| 157 | focal adhesion assembly (GO:0048041) | 2.96187906 |
| 158 | cell-substrate adherens junction assembly (GO:0007045) | 2.96187906 |
| 159 | trophectodermal cell differentiation (GO:0001829) | 2.95691188 |
| 160 | response to oxygen radical (GO:0000305) | 2.95045060 |
| 161 | monovalent inorganic cation homeostasis (GO:0055067) | 2.93605977 |
| 162 | regulation of cardioblast differentiation (GO:0051890) | 2.93530494 |
| 163 | regulation of epidermal cell differentiation (GO:0045604) | 2.92177452 |
| 164 | vitamin transport (GO:0051180) | 2.92074213 |
| 165 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.90834444 |
| 166 | * response to iron ion (GO:0010039) | 2.90742674 |
| 167 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.88584854 |
| 168 | activation of Rac GTPase activity (GO:0032863) | 2.87004992 |
| 169 | serine transport (GO:0032329) | 2.85766197 |
| 170 | mammary gland epithelial cell proliferation (GO:0033598) | 2.85179225 |
| 171 | embryonic foregut morphogenesis (GO:0048617) | 2.84412732 |
| 172 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.83607952 |
| 173 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.83583954 |
| 174 | regulation of skeletal muscle contraction (GO:0014819) | 2.83508545 |
| 175 | mammary gland alveolus development (GO:0060749) | 2.81647411 |
| 176 | cellular glucuronidation (GO:0052695) | 2.80735293 |
| 177 | xenobiotic catabolic process (GO:0042178) | 2.80583520 |
| 178 | hormone catabolic process (GO:0042447) | 2.79851481 |
| 179 | adherens junction assembly (GO:0034333) | 2.78568225 |
| 180 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.77982601 |
| 181 | response to gonadotropin (GO:0034698) | 2.77024208 |
| 182 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.76682376 |
| 183 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.76682376 |
| 184 | amyloid precursor protein metabolic process (GO:0042982) | 2.76396650 |
| 185 | desmosome organization (GO:0002934) | 2.74044344 |
| 186 | TOR signaling (GO:0031929) | 2.72980073 |
| 187 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.72595168 |
| 188 | ER overload response (GO:0006983) | 2.72017205 |
| 189 | negative regulation of cholesterol transport (GO:0032375) | 2.71440834 |
| 190 | negative regulation of adherens junction organization (GO:1903392) | 2.70527147 |
| 191 | negative regulation of focal adhesion assembly (GO:0051895) | 2.70527147 |
| 192 | negative regulation of cell junction assembly (GO:1901889) | 2.70527147 |
| 193 | glucose catabolic process (GO:0006007) | 2.67137608 |
| 194 | extracellular fibril organization (GO:0043206) | 11.2836356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 6.25817182 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.16630456 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.45448810 |
| 4 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.16680757 |
| 5 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.86192626 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.82276957 |
| 7 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.71781381 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.68130923 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.62211389 |
| 10 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.55745332 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.51772555 |
| 12 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.49798970 |
| 13 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.47946219 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46282193 |
| 15 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.44586668 |
| 16 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.36320177 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.34085770 |
| 18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.30727981 |
| 19 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.23286827 |
| 20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.13598610 |
| 21 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.06141710 |
| 22 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.05224837 |
| 23 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.01236125 |
| 24 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.95647062 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.95540385 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.95034497 |
| 27 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.94880220 |
| 28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.91075740 |
| 29 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.88165396 |
| 30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.86540282 |
| 31 | VDR_22108803_ChIP-Seq_LS180_Human | 1.82778913 |
| 32 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.82442020 |
| 33 | * ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.82088286 |
| 34 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.74794839 |
| 35 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.74185396 |
| 36 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.73415545 |
| 37 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.73130948 |
| 38 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.72976549 |
| 39 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.69030369 |
| 40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68995777 |
| 41 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.68227447 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.68095606 |
| 43 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.65096579 |
| 44 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.64705265 |
| 45 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.62751784 |
| 46 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60464969 |
| 47 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.57889820 |
| 48 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.57195126 |
| 49 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55030711 |
| 50 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.53729770 |
| 51 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.53256394 |
| 52 | MYC_22102868_ChIP-Seq_BL_Human | 1.50605378 |
| 53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49766699 |
| 54 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46375001 |
| 55 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.46167134 |
| 56 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.45720158 |
| 57 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.45720158 |
| 58 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.45501297 |
| 59 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.45341588 |
| 60 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.45016399 |
| 61 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44327086 |
| 62 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44092951 |
| 63 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.43833529 |
| 64 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42852703 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38216327 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37244090 |
| 67 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.36844898 |
| 68 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.36755454 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.36357603 |
| 70 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.35520421 |
| 71 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34652825 |
| 72 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.34265372 |
| 73 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34156778 |
| 74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34040266 |
| 75 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.31793336 |
| 76 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.31747996 |
| 77 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.31586853 |
| 78 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.30964875 |
| 79 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.28789223 |
| 80 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28247537 |
| 81 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.27698373 |
| 82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27553923 |
| 83 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27387415 |
| 84 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.26339041 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26309755 |
| 86 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.25552046 |
| 87 | RXR_22108803_ChIP-Seq_LS180_Human | 1.23724860 |
| 88 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.23231142 |
| 89 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23073805 |
| 90 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.21949514 |
| 91 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.21684643 |
| 92 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21477304 |
| 93 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21125688 |
| 94 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21018476 |
| 95 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20683238 |
| 96 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20491326 |
| 97 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19379302 |
| 98 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18129174 |
| 99 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.18004367 |
| 100 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17909933 |
| 101 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.17443988 |
| 102 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.14080794 |
| 103 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.13687410 |
| 104 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.12910484 |
| 105 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.11024193 |
| 106 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.09520388 |
| 107 | P68_20966046_ChIP-Seq_HELA_Human | 1.09346637 |
| 108 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.08939654 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08788055 |
| 110 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08311600 |
| 111 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08256766 |
| 112 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07572579 |
| 113 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06692433 |
| 114 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05748991 |
| 115 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03778168 |
| 116 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.02697317 |
| 117 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.02455049 |
| 118 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.01922268 |
| 119 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01148391 |
| 120 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.00319583 |
| 121 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00051786 |
| 122 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99164978 |
| 123 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.99112813 |
| 124 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98657246 |
| 125 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97770328 |
| 126 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97180794 |
| 127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96151526 |
| 128 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.95399944 |
| 129 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.95068687 |
| 130 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.94510499 |
| 131 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94457992 |
| 132 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.93625201 |
| 133 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.93577921 |
| 134 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93572618 |
| 135 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93495692 |
| 136 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93066615 |
| 137 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92753167 |
| 138 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92363282 |
| 139 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91283176 |
| 140 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91283176 |
| 141 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.91173582 |
| 142 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90851284 |
| 143 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.90759970 |
| 144 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90485990 |
| 145 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.90351450 |
| 146 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.90351450 |
| 147 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.90351450 |
| 148 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90061848 |
| 149 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90061848 |
| 150 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.89026007 |
| 151 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.89013480 |
| 152 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88569388 |
| 153 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.88262426 |
| 154 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.88159079 |
| 155 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.88079626 |
| 156 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86927815 |
| 157 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.86443918 |
| 158 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82315627 |
| 159 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81750664 |
| 160 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.81449218 |
| 161 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.80276405 |
| 162 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.79959799 |
| 163 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.79596049 |
| 164 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.78787655 |
| 165 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.77878096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001873_stomach_inflammation | 6.12655090 |
| 2 | * MP0001664_abnormal_digestion | 4.20739010 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.56319178 |
| 4 | * MP0000470_abnormal_stomach_morphology | 3.25622191 |
| 5 | MP0003123_paternal_imprinting | 3.03108253 |
| 6 | MP0005076_abnormal_cell_differentiation | 2.90417993 |
| 7 | MP0000383_abnormal_hair_follicle | 2.59660466 |
| 8 | MP0004381_abnormal_hair_follicle | 2.57836757 |
| 9 | MP0001663_abnormal_digestive_system | 2.17861075 |
| 10 | MP0004782_abnormal_surfactant_physiolog | 2.11196454 |
| 11 | MP0000538_abnormal_urinary_bladder | 2.02450412 |
| 12 | MP0008004_abnormal_stomach_pH | 17.8578664 |
| 13 | MP0002249_abnormal_larynx_morphology | 1.98343468 |
| 14 | MP0000427_abnormal_hair_cycle | 1.97773355 |
| 15 | MP0005381_digestive/alimentary_phenotyp | 1.88759244 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 1.86851197 |
| 17 | MP0004233_abnormal_muscle_weight | 1.86730801 |
| 18 | MP0000377_abnormal_hair_follicle | 1.85680067 |
| 19 | MP0000627_abnormal_mammary_gland | 1.81603368 |
| 20 | MP0003941_abnormal_skin_development | 1.78709099 |
| 21 | MP0001666_abnormal_nutrient_absorption | 1.76249525 |
| 22 | MP0005451_abnormal_body_composition | 1.73189187 |
| 23 | MP0005165_increased_susceptibility_to | 1.72715023 |
| 24 | MP0000579_abnormal_nail_morphology | 1.66865830 |
| 25 | MP0002751_abnormal_autonomic_nervous | 1.60100245 |
| 26 | MP0002089_abnormal_postnatal_growth/wei | 1.58285982 |
| 27 | MP0001727_abnormal_embryo_implantation | 1.57145512 |
| 28 | MP0003942_abnormal_urinary_system | 1.55520215 |
| 29 | MP0009672_abnormal_birth_weight | 1.55350196 |
| 30 | MP0005083_abnormal_biliary_tract | 1.46274155 |
| 31 | MP0000534_abnormal_ureter_morphology | 1.45343338 |
| 32 | MP0009840_abnormal_foam_cell | 1.44424373 |
| 33 | MP0005248_abnormal_Harderian_gland | 1.43067932 |
| 34 | MP0005075_abnormal_melanosome_morpholog | 1.36338761 |
| 35 | MP0003693_abnormal_embryo_hatching | 1.31965905 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.31021571 |
| 37 | MP0003936_abnormal_reproductive_system | 1.29645735 |
| 38 | MP0001881_abnormal_mammary_gland | 1.24826973 |
| 39 | MP0000750_abnormal_muscle_regeneration | 1.24512107 |
| 40 | MP0000678_abnormal_parathyroid_gland | 1.23641715 |
| 41 | MP0004264_abnormal_extraembryonic_tissu | 1.23237128 |
| 42 | MP0005423_abnormal_somatic_nervous | 1.22928189 |
| 43 | MP0008260_abnormal_autophagy | 1.22139821 |
| 44 | MP0005085_abnormal_gallbladder_physiolo | 1.17002581 |
| 45 | MP0005409_darkened_coat_color | 1.12519527 |
| 46 | MP0003186_abnormal_redox_activity | 1.11136762 |
| 47 | MP0003283_abnormal_digestive_organ | 1.09809684 |
| 48 | MP0006054_spinal_hemorrhage | 1.07250936 |
| 49 | MP0001919_abnormal_reproductive_system | 1.06371286 |
| 50 | MP0002909_abnormal_adrenal_gland | 0.96429523 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 0.96078413 |
| 52 | * MP0000477_abnormal_intestine_morphology | 0.95797002 |
| 53 | MP0005365_abnormal_bile_salt | 0.93148926 |
| 54 | MP0003183_abnormal_peptide_metabolism | 0.91169176 |
| 55 | MP0010030_abnormal_orbit_morphology | 0.90285141 |
| 56 | MP0002160_abnormal_reproductive_system | 0.89130360 |
| 57 | MP0005646_abnormal_pituitary_gland | 0.88892903 |
| 58 | MP0008995_early_reproductive_senescence | 0.87876717 |
| 59 | MP0003787_abnormal_imprinting | 0.87809081 |
| 60 | MP0003115_abnormal_respiratory_system | 0.86937591 |
| 61 | MP0000371_diluted_coat_color | 0.86148476 |
| 62 | MP0008875_abnormal_xenobiotic_pharmacok | 0.85109166 |
| 63 | MP0004957_abnormal_blastocyst_morpholog | 0.83941643 |
| 64 | MP0000462_abnormal_digestive_system | 0.83169301 |
| 65 | MP0000490_abnormal_crypts_of | 0.76102558 |
| 66 | MP0009384_cardiac_valve_regurgitation | 0.74866479 |
| 67 | MP0002127_abnormal_cardiovascular_syste | 0.74439187 |
| 68 | MP0001186_pigmentation_phenotype | 0.73917485 |
| 69 | MP0003868_abnormal_feces_composition | 0.73189874 |
| 70 | MP0002184_abnormal_innervation | 0.72905301 |
| 71 | MP0010329_abnormal_lipoprotein_level | 0.71676481 |
| 72 | MP0009703_decreased_birth_body | 0.71278351 |
| 73 | MP0010094_abnormal_chromosome_stability | 0.70549695 |
| 74 | MP0005266_abnormal_metabolism | 0.70298349 |
| 75 | MP0000537_abnormal_urethra_morphology | 0.69432564 |
| 76 | MP0005636_abnormal_mineral_homeostasis | 0.68660827 |
| 77 | MP0000613_abnormal_salivary_gland | 0.68467705 |
| 78 | MP0002108_abnormal_muscle_morphology | 0.67665599 |
| 79 | MP0008872_abnormal_physiological_respon | 0.67336388 |
| 80 | MP0002139_abnormal_hepatobiliary_system | 0.65839494 |
| 81 | MP0002166_altered_tumor_susceptibility | 0.64542546 |
| 82 | MP0002075_abnormal_coat/hair_pigmentati | 0.64132110 |
| 83 | MP0002080_prenatal_lethality | 0.62956813 |
| 84 | MP0001697_abnormal_embryo_size | 0.62344739 |
| 85 | MP0004484_altered_response_of | 0.62004242 |
| 86 | MP0005375_adipose_tissue_phenotype | 0.61580158 |
| 87 | MP0002088_abnormal_embryonic_growth/wei | 0.61261886 |
| 88 | MP0000681_abnormal_thyroid_gland | 0.60482575 |
| 89 | MP0004185_abnormal_adipocyte_glucose | 0.59463791 |
| 90 | MP0001340_abnormal_eyelid_morphology | 0.58821472 |
| 91 | MP0008932_abnormal_embryonic_tissue | 0.58409085 |
| 92 | MP0001672_abnormal_embryogenesis/_devel | 0.57975919 |
| 93 | MP0010155_abnormal_intestine_physiology | 0.57431781 |
| 94 | MP0004858_abnormal_nervous_system | 0.56696666 |
| 95 | MP0002234_abnormal_pharynx_morphology | 0.56537214 |
| 96 | MP0002796_impaired_skin_barrier | 0.54323870 |
| 97 | MP0000467_abnormal_esophagus_morphology | 0.54033764 |
| 98 | MP0003075_altered_response_to | 0.53552265 |
| 99 | MP0002877_abnormal_melanocyte_morpholog | 0.52149037 |
| 100 | MP0001243_abnormal_dermal_layer | 0.49724469 |
| 101 | MP0002118_abnormal_lipid_homeostasis | 0.45745546 |
| 102 | MP0004947_skin_inflammation | 0.44262274 |
| 103 | MP0003191_abnormal_cellular_cholesterol | 0.42239378 |
| 104 | MP0002009_preneoplasia | 0.41543441 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.41175428 |
| 106 | MP0003953_abnormal_hormone_level | 0.41170059 |
| 107 | MP0002078_abnormal_glucose_homeostasis | 0.38229711 |
| 108 | MP0003866_abnormal_defecation | 0.37397529 |
| 109 | MP0005166_decreased_susceptibility_to | 0.36588599 |
| 110 | MP0008873_increased_physiological_sensi | 0.36364686 |
| 111 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.35975098 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.35740835 |
| 113 | MP0003252_abnormal_bile_duct | 0.35663508 |
| 114 | MP0009780_abnormal_chondrocyte_physiolo | 0.34262110 |
| 115 | MP0001216_abnormal_epidermal_layer | 0.33596868 |
| 116 | MP0010678_abnormal_skin_adnexa | 0.32843754 |
| 117 | MP0005360_urolithiasis | 0.32742927 |
| 118 | MP0003724_increased_susceptibility_to | 0.32354090 |
| 119 | MP0002060_abnormal_skin_morphology | 0.32165557 |
| 120 | MP0010352_gastrointestinal_tract_polyps | 0.32032422 |
| 121 | MP0000609_abnormal_liver_physiology | 0.31654602 |
| 122 | MP0001845_abnormal_inflammatory_respons | 0.30764965 |
| 123 | MP0005319_abnormal_enzyme/_coenzyme | 0.29603612 |
| 124 | MP0002970_abnormal_white_adipose | 0.28677892 |
| 125 | MP0005408_hypopigmentation | 0.27836932 |
| 126 | MP0001849_ear_inflammation | 0.27394578 |
| 127 | MP0003638_abnormal_response/metabolism_ | 0.26981289 |
| 128 | MP0009642_abnormal_blood_homeostasis | 0.26842807 |
| 129 | MP0003453_abnormal_keratinocyte_physiol | 0.26753435 |
| 130 | MP0003329_amyloid_beta_deposits | 0.26743334 |
| 131 | MP0000367_abnormal_coat/_hair | 0.26303102 |
| 132 | MP0000598_abnormal_liver_morphology | 0.26081820 |
| 133 | MP0005376_homeostasis/metabolism_phenot | 0.25346204 |
| 134 | MP0004130_abnormal_muscle_cell | 0.24761652 |
| 135 | MP0004043_abnormal_pH_regulation | 0.24575523 |
| 136 | MP0003119_abnormal_digestive_system | 0.23988569 |
| 137 | MP0005332_abnormal_amino_acid | 0.23367063 |
| 138 | MP0005501_abnormal_skin_physiology | 0.21895837 |
| 139 | MP0004019_abnormal_vitamin_homeostasis | 0.21136934 |
| 140 | MP0000013_abnormal_adipose_tissue | 0.20781640 |
| 141 | MP0003656_abnormal_erythrocyte_physiolo | 0.20651370 |
| 142 | MP0005275_abnormal_skin_tensile | 0.18332806 |
| 143 | MP0005464_abnormal_platelet_physiology | 0.17987674 |
| 144 | * MP0002019_abnormal_tumor_incidence | 0.17873182 |
| 145 | MP0009643_abnormal_urine_homeostasis | 0.17157942 |
| 146 | MP0008961_abnormal_basal_metabolism | 0.17069136 |
| 147 | MP0010771_integument_phenotype | 0.16820000 |
| 148 | MP0005310_abnormal_salivary_gland | 0.16618653 |
| 149 | MP0002837_dystrophic_cardiac_calcinosis | 0.16239091 |
| 150 | MP0005452_abnormal_adipose_tissue | 0.15829962 |
| 151 | MP0005367_renal/urinary_system_phenotyp | 0.15120018 |
| 152 | MP0000516_abnormal_urinary_system | 0.15120018 |
| 153 | MP0004859_abnormal_synaptic_plasticity | 0.15051359 |
| 154 | MP0000465_gastrointestinal_hemorrhage | 0.14866579 |
| 155 | MP0002098_abnormal_vibrissa_morphology | 0.14715527 |
| 156 | MP0009053_abnormal_anal_canal | 0.14607551 |
| 157 | MP0009931_abnormal_skin_appearance | 0.14598773 |
| 158 | MP0003690_abnormal_glial_cell | 0.14082824 |
| 159 | MP0000604_amyloidosis | 0.13810432 |
| 160 | MP0005666_abnormal_adipose_tissue | 0.13594508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 9.65141881 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 9.06054583 |
| 3 | J-shaped sella turcica (HP:0002680) | 7.24480586 |
| 4 | Asymmetry of the thorax (HP:0001555) | 6.38936867 |
| 5 | Microglossia (HP:0000171) | 5.19230590 |
| 6 | Megaloblastic anemia (HP:0001889) | 5.15340522 |
| 7 | Septate vagina (HP:0001153) | 5.04767591 |
| 8 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.94181743 |
| 9 | Concave nail (HP:0001598) | 4.76420119 |
| 10 | Abnormality of vitamin B metabolism (HP:0004340) | 4.66875364 |
| 11 | Palpitations (HP:0001962) | 4.54102872 |
| 12 | Goiter (HP:0000853) | 4.39885340 |
| 13 | Absent frontal sinuses (HP:0002688) | 4.38142280 |
| 14 | Gout (HP:0001997) | 4.37485158 |
| 15 | Distal lower limb muscle weakness (HP:0009053) | 4.21022566 |
| 16 | Abnormality of vitamin metabolism (HP:0100508) | 4.20971333 |
| 17 | Deformed sella turcica (HP:0002681) | 4.15935276 |
| 18 | Syncope (HP:0001279) | 4.15271388 |
| 19 | Woolly hair (HP:0002224) | 4.01982318 |
| 20 | Breast carcinoma (HP:0003002) | 3.88338588 |
| 21 | Intrahepatic cholestasis (HP:0001406) | 3.82685302 |
| 22 | Abnormality of purine metabolism (HP:0004352) | 3.62348907 |
| 23 | Abnormality of the umbilical cord (HP:0010881) | 3.54579151 |
| 24 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.48092470 |
| 25 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 3.47679921 |
| 26 | Ventricular fibrillation (HP:0001663) | 3.37569782 |
| 27 | Abnormality of the frontal sinuses (HP:0002687) | 3.20744862 |
| 28 | Frequent falls (HP:0002359) | 3.18825362 |
| 29 | Germ cell neoplasia (HP:0100728) | 3.14883017 |
| 30 | Thin bony cortex (HP:0002753) | 3.08210436 |
| 31 | Hyperparathyroidism (HP:0000843) | 3.07948146 |
| 32 | Enlarged penis (HP:0000040) | 3.06606621 |
| 33 | Arterial tortuosity (HP:0005116) | 3.02033133 |
| 34 | Amelogenesis imperfecta (HP:0000705) | 3.01552307 |
| 35 | Back pain (HP:0003418) | 3.01458342 |
| 36 | Spinal cord compression (HP:0002176) | 2.98565169 |
| 37 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.98477129 |
| 38 | Sparse lateral eyebrow (HP:0005338) | 2.94634871 |
| 39 | Chromsome breakage (HP:0040012) | 2.94070436 |
| 40 | Ventricular arrhythmia (HP:0004308) | 2.92140846 |
| 41 | Long toe (HP:0010511) | 2.90429870 |
| 42 | Glomerulosclerosis (HP:0000096) | 2.83008708 |
| 43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.82740000 |
| 44 | Abnormality of the sella turcica (HP:0002679) | 2.82692289 |
| 45 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.77527125 |
| 46 | Macroorchidism (HP:0000053) | 2.76015731 |
| 47 | Increased purine levels (HP:0004368) | 2.75196456 |
| 48 | Hyperuricemia (HP:0002149) | 2.75196456 |
| 49 | Testicular atrophy (HP:0000029) | 2.72932306 |
| 50 | Deep venous thrombosis (HP:0002625) | 2.66005724 |
| 51 | Vascular tortuosity (HP:0004948) | 2.65570473 |
| 52 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.65361535 |
| 53 | Syringomyelia (HP:0003396) | 2.59644672 |
| 54 | Spinal cord lesions (HP:0100561) | 2.59644672 |
| 55 | Ventricular tachycardia (HP:0004756) | 2.57820280 |
| 56 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.57412081 |
| 57 | Reticulocytosis (HP:0001923) | 2.56500237 |
| 58 | Flat acetabular roof (HP:0003180) | 2.55830853 |
| 59 | Hemorrhage of the eye (HP:0011885) | 2.52097216 |
| 60 | Conjugated hyperbilirubinemia (HP:0002908) | 2.49400617 |
| 61 | Hyporeflexia of lower limbs (HP:0002600) | 2.48836500 |
| 62 | Aortic dissection (HP:0002647) | 2.48814886 |
| 63 | Hypercortisolism (HP:0001578) | 2.43102195 |
| 64 | Agitation (HP:0000713) | 2.41175700 |
| 65 | Axonal loss (HP:0003447) | 2.40927153 |
| 66 | Hemiplegia (HP:0002301) | 2.40443971 |
| 67 | Increased cerebral lipofuscin (HP:0011813) | 2.36282583 |
| 68 | Depressed nasal tip (HP:0000437) | 2.33671347 |
| 69 | Vascular calcification (HP:0004934) | 2.32110888 |
| 70 | Micronodular cirrhosis (HP:0001413) | 2.31381561 |
| 71 | Infantile muscular hypotonia (HP:0008947) | 2.30146122 |
| 72 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.27267489 |
| 73 | Abnormal cartilage morphology (HP:0002763) | 2.27224242 |
| 74 | Bulbar palsy (HP:0001283) | 2.27078041 |
| 75 | Ketoacidosis (HP:0001993) | 2.26171682 |
| 76 | Deep philtrum (HP:0002002) | 2.26168164 |
| 77 | Abnormality of the gastric mucosa (HP:0004295) | 2.23825021 |
| 78 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.23713000 |
| 79 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.23713000 |
| 80 | Single umbilical artery (HP:0001195) | 2.23713000 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.18112878 |
| 82 | Pterygium (HP:0001059) | 2.16801961 |
| 83 | Abnormality of nail color (HP:0100643) | 2.16124363 |
| 84 | Cardiovascular calcification (HP:0011915) | 2.15727791 |
| 85 | Lymphangioma (HP:0100764) | 2.15664995 |
| 86 | Ulnar claw (HP:0001178) | 2.15448376 |
| 87 | Abnormality of nucleobase metabolism (HP:0010932) | 2.14805545 |
| 88 | Ketosis (HP:0001946) | 2.12818594 |
| 89 | Curly hair (HP:0002212) | 2.11809040 |
| 90 | Increased variability in muscle fiber diameter (HP:0003557) | 2.10165568 |
| 91 | Short nail (HP:0001799) | 2.09444089 |
| 92 | Focal segmental glomerulosclerosis (HP:0000097) | 2.09042315 |
| 93 | Atrophic scars (HP:0001075) | 2.09036557 |
| 94 | Sudden cardiac death (HP:0001645) | 2.07291647 |
| 95 | Abnormality of reticulocytes (HP:0004312) | 2.05868402 |
| 96 | Exostoses (HP:0100777) | 2.05564261 |
| 97 | Congenital glaucoma (HP:0001087) | 2.05226650 |
| 98 | Esophageal varix (HP:0002040) | 2.05065273 |
| 99 | Hyperacusis (HP:0010780) | 2.04237156 |
| 100 | Hyperammonemia (HP:0001987) | 2.03342966 |
| 101 | Cupped ribs (HP:0000887) | 2.01065598 |
| 102 | Abnormal number of erythroid precursors (HP:0012131) | 10.1775120 |
| 103 | Xanthomatosis (HP:0000991) | 1.99605149 |
| 104 | Hypoalphalipoproteinemia (HP:0003233) | 1.99307423 |
| 105 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 1.99276454 |
| 106 | Generalized amyotrophy (HP:0003700) | 1.99150447 |
| 107 | Renal salt wasting (HP:0000127) | 1.98787743 |
| 108 | Easy fatigability (HP:0003388) | 1.98292904 |
| 109 | Hypoparathyroidism (HP:0000829) | 1.98202094 |
| 110 | Ankyloglossia (HP:0010296) | 1.97585253 |
| 111 | Buphthalmos (HP:0000557) | 1.95258464 |
| 112 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.93050090 |
| 113 | Broad face (HP:0000283) | 1.92403727 |
| 114 | Bicornuate uterus (HP:0000813) | 1.92383243 |
| 115 | Hypoglycemic coma (HP:0001325) | 1.89784253 |
| 116 | Generalized hypopigmentation of hair (HP:0011358) | 1.88647425 |
| 117 | Conjunctival hamartoma (HP:0100780) | 1.88603576 |
| 118 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.88578970 |
| 119 | Pustule (HP:0200039) | 1.88077752 |
| 120 | Cervical subluxation (HP:0003308) | 1.87987163 |
| 121 | Abnormal gallbladder physiology (HP:0012438) | 1.87718467 |
| 122 | Cholecystitis (HP:0001082) | 1.87718467 |
| 123 | Lethargy (HP:0001254) | 1.84665712 |
| 124 | Tubulointerstitial nephritis (HP:0001970) | 1.83792559 |
| 125 | Abnormal urine phosphate concentration (HP:0012599) | 1.81856206 |
| 126 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.81743031 |
| 127 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.81561740 |
| 128 | Termporal pattern (HP:0011008) | 1.81248411 |
| 129 | Insidious onset (HP:0003587) | 1.81248411 |
| 130 | Malnutrition (HP:0004395) | 1.80553396 |
| 131 | Tubulointerstitial fibrosis (HP:0005576) | 1.79520161 |
| 132 | Flat capital femoral epiphysis (HP:0003370) | 1.79386989 |
| 133 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.79201256 |
| 134 | Abdominal distention (HP:0003270) | 1.78548292 |
| 135 | Hypokinesia (HP:0002375) | 1.77095718 |
| 136 | Restlessness (HP:0000711) | 1.76978226 |
| 137 | Progressive muscle weakness (HP:0003323) | 1.76580538 |
| 138 | Hypopigmentation of the fundus (HP:0007894) | 1.76314564 |
| 139 | High pitched voice (HP:0001620) | 1.75856685 |
| 140 | Abnormality of the preputium (HP:0100587) | 1.75813060 |
| 141 | Abnormality of the Achilles tendon (HP:0005109) | 1.75740247 |
| 142 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.75504385 |
| 143 | Pili torti (HP:0003777) | 1.75349869 |
| 144 | Paresthesia (HP:0003401) | 1.74249303 |
| 145 | Prolonged neonatal jaundice (HP:0006579) | 1.74104661 |
| 146 | Hyperglycemia (HP:0003074) | 1.73113089 |
| 147 | Meningioma (HP:0002858) | 1.72614083 |
| 148 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.72266815 |
| 149 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.71742220 |
| 150 | Fasciculations (HP:0002380) | 1.71496418 |
| 151 | Growth hormone excess (HP:0000845) | 1.71200188 |
| 152 | Thyroid carcinoma (HP:0002890) | 1.70793835 |
| 153 | Milia (HP:0001056) | 1.70472472 |
| 154 | Abnormality of the thoracic spine (HP:0100711) | 1.70150231 |
| 155 | Cone-rod dystrophy (HP:0000548) | 1.70061723 |
| 156 | Achilles tendon contracture (HP:0001771) | 1.69533172 |
| 157 | Short thumb (HP:0009778) | 1.67659708 |
| 158 | Spastic tetraparesis (HP:0001285) | 1.66252727 |
| 159 | Turricephaly (HP:0000262) | 1.65626578 |
| 160 | Abnormal tarsal ossification (HP:0008369) | 1.65264675 |
| 161 | Macrocytic anemia (HP:0001972) | 1.64354913 |
| 162 | Leiomyosarcoma (HP:0100243) | 1.64130898 |
| 163 | Uterine leiomyosarcoma (HP:0002891) | 1.64130898 |
| 164 | Fragile nails (HP:0001808) | 1.63590075 |
| 165 | Seborrheic dermatitis (HP:0001051) | 1.63145770 |
| 166 | Hyperphosphatemia (HP:0002905) | 1.60740240 |
| 167 | Cutaneous melanoma (HP:0012056) | 1.60615289 |
| 168 | Diaphragmatic weakness (HP:0009113) | 1.59848079 |
| 169 | Neoplasm of the thyroid gland (HP:0100031) | 1.59553400 |
| 170 | Periodontitis (HP:0000704) | 1.59368266 |
| 171 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.59239187 |
| 172 | Ectopia lentis (HP:0001083) | 1.58892558 |
| 173 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.58571741 |
| 174 | Patellar dislocation (HP:0002999) | 1.58337204 |
| 175 | Fragile skin (HP:0001030) | 1.55897616 |
| 176 | Polygenic inheritance (HP:0010982) | 1.54959218 |
| 177 | Aneurysm (HP:0002617) | 1.54924672 |
| 178 | Testicular neoplasm (HP:0010788) | 1.54836355 |
| 179 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.54786444 |
| 180 | Macroglossia (HP:0000158) | 1.54632224 |
| 181 | Abnormality of oral frenula (HP:0000190) | 1.53979829 |
| 182 | Death in childhood (HP:0003819) | 1.52422395 |
| 183 | Onycholysis (HP:0001806) | 1.52202093 |
| 184 | Plantar hyperkeratosis (HP:0007556) | 1.52159404 |
| 185 | Spastic diplegia (HP:0001264) | 1.49134496 |
| 186 | Bundle branch block (HP:0011710) | 1.48715261 |
| 187 | Spinal rigidity (HP:0003306) | 1.48655302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 5.70416757 |
| 2 | MST4 | 4.53770622 |
| 3 | SIK1 | 4.08636198 |
| 4 | MST1R | 4.02743588 |
| 5 | SCYL2 | 3.85398557 |
| 6 | MAPKAPK3 | 3.17143412 |
| 7 | EPHA2 | 3.06508642 |
| 8 | SMG1 | 2.67366093 |
| 9 | IRAK3 | 2.11459550 |
| 10 | TRIB3 | 2.04265326 |
| 11 | ERBB4 | 13.5069450 |
| 12 | NEK6 | 1.95923153 |
| 13 | PKN2 | 1.89932576 |
| 14 | VRK2 | 1.67900168 |
| 15 | LRRK2 | 1.63225037 |
| 16 | MET | 1.61435808 |
| 17 | MAP3K12 | 1.58408898 |
| 18 | MAP3K9 | 1.56635122 |
| 19 | KSR2 | 1.55552798 |
| 20 | RIPK4 | 1.51091363 |
| 21 | ILK | 1.35949900 |
| 22 | PIK3CG | 1.35244015 |
| 23 | MAP3K2 | 1.30257737 |
| 24 | TESK2 | 1.26767799 |
| 25 | STK10 | 1.19312425 |
| 26 | CDK7 | 1.19253929 |
| 27 | FER | 1.13485068 |
| 28 | CHUK | 1.12828778 |
| 29 | MAP2K2 | 1.11784489 |
| 30 | MAP2K1 | 1.11776849 |
| 31 | FGFR4 | 1.08064115 |
| 32 | NUAK1 | 1.07010952 |
| 33 | BCKDK | 1.05266113 |
| 34 | PTK6 | 1.03670371 |
| 35 | LMTK2 | 0.99996072 |
| 36 | PRKG2 | 0.97425537 |
| 37 | FRK | 0.94856546 |
| 38 | ERN1 | 0.93144935 |
| 39 | PBK | 0.92515959 |
| 40 | MYLK | 0.88756570 |
| 41 | SIK3 | 0.88619666 |
| 42 | PAK3 | 0.87350379 |
| 43 | RIPK1 | 0.86552656 |
| 44 | FYN | 0.83902647 |
| 45 | STK39 | 0.83605108 |
| 46 | RPS6KB1 | 0.81705678 |
| 47 | PRKCI | 0.79600296 |
| 48 | PDGFRB | 0.75734470 |
| 49 | IRAK2 | 0.75452673 |
| 50 | EIF2AK1 | 0.74603386 |
| 51 | SRPK1 | 0.73055123 |
| 52 | WNK4 | 0.71495323 |
| 53 | NEK1 | 0.70271397 |
| 54 | TESK1 | 0.70215038 |
| 55 | MTOR | 0.68078784 |
| 56 | TAF1 | 0.66701825 |
| 57 | PDK3 | 0.65483641 |
| 58 | PDK4 | 0.65483641 |
| 59 | TAOK1 | 0.65184030 |
| 60 | NME1 | 0.63950569 |
| 61 | DDR2 | 0.63845979 |
| 62 | ROCK2 | 0.63101881 |
| 63 | MAPKAPK2 | 0.61102683 |
| 64 | PIM2 | 0.60328873 |
| 65 | ICK | 0.58987186 |
| 66 | EEF2K | 0.57073859 |
| 67 | ZAP70 | 0.56831687 |
| 68 | TBK1 | 0.56149202 |
| 69 | CSF1R | 0.54287147 |
| 70 | MAP3K8 | 0.52455293 |
| 71 | BMX | 0.49526893 |
| 72 | PTK2 | 0.48237430 |
| 73 | SRC | 0.47923729 |
| 74 | PAK4 | 0.47035087 |
| 75 | CDK12 | 0.46057002 |
| 76 | EPHB1 | 0.45468437 |
| 77 | ERBB2 | 0.45358747 |
| 78 | PDPK1 | 0.44948608 |
| 79 | RPS6KA4 | 0.43877107 |
| 80 | PDK2 | 0.42064487 |
| 81 | RPS6KA2 | 0.41370153 |
| 82 | IKBKB | 0.38421338 |
| 83 | RET | 0.38299360 |
| 84 | EIF2AK2 | 0.37521888 |
| 85 | ROCK1 | 0.37389782 |
| 86 | IKBKE | 0.36287189 |
| 87 | MAP3K10 | 0.35983857 |
| 88 | HIPK2 | 0.35716711 |
| 89 | IRAK4 | 0.35078984 |
| 90 | DAPK1 | 0.34382766 |
| 91 | RPS6KL1 | 0.33603767 |
| 92 | RPS6KC1 | 0.33603767 |
| 93 | MAP3K3 | 0.33550822 |
| 94 | AKT2 | 0.33465313 |
| 95 | PDK1 | 0.33155860 |
| 96 | GRK6 | 0.32810008 |
| 97 | RPS6KB2 | 0.31722922 |
| 98 | TTN | 0.30799632 |
| 99 | MAP3K1 | 0.30751824 |
| 100 | DMPK | 0.30581944 |
| 101 | AURKA | 0.29714330 |
| 102 | LIMK1 | 0.29624444 |
| 103 | CSK | 0.29296194 |
| 104 | CAMKK1 | 0.28523706 |
| 105 | MELK | 0.28197540 |
| 106 | MAP3K13 | 0.28174206 |
| 107 | MINK1 | 0.26328169 |
| 108 | NTRK1 | 0.26049748 |
| 109 | MATK | 0.25791066 |
| 110 | PDGFRA | 0.25568210 |
| 111 | KSR1 | 0.25316979 |
| 112 | EGFR | 0.24983728 |
| 113 | AURKB | 0.24587263 |
| 114 | BRSK1 | 0.24310117 |
| 115 | TAOK2 | 0.24228044 |
| 116 | FGFR2 | 0.24144534 |
| 117 | CAMK2B | 0.23347649 |
| 118 | MAPK4 | 0.23091522 |
| 119 | PRPF4B | 0.22582599 |
| 120 | RPS6KA6 | 0.21957421 |
| 121 | ALK | 0.21808074 |
| 122 | BMPR2 | 0.20794650 |
| 123 | YES1 | 0.19886683 |
| 124 | MAPK8 | 0.18919724 |
| 125 | CDK19 | 0.18743944 |
| 126 | ARAF | 0.18146735 |
| 127 | TSSK6 | 0.17858095 |
| 128 | CAMK2D | 0.17777079 |
| 129 | PRKD2 | 0.17705170 |
| 130 | TYRO3 | 0.17633973 |
| 131 | PRKD1 | 0.17578482 |
| 132 | PRKCQ | 0.17155708 |
| 133 | PRKAA2 | 0.17099629 |
| 134 | PAK6 | 0.16422057 |
| 135 | MAPK11 | 0.16111034 |
| 136 | JAK2 | 0.15913042 |
| 137 | PRKCZ | 0.15844549 |
| 138 | MAPKAPK5 | 0.15536915 |
| 139 | PIK3CA | 0.15374774 |
| 140 | CDK6 | 0.14998304 |
| 141 | CAMK2G | 0.14910092 |
| 142 | FGR | 0.14785474 |
| 143 | CDK8 | 0.14452877 |
| 144 | MAP2K6 | 0.13927748 |
| 145 | LATS1 | 0.13491888 |
| 146 | PHKG1 | 0.13153726 |
| 147 | PHKG2 | 0.13153726 |
| 148 | PAK2 | 0.13075268 |
| 149 | RAF1 | 0.12830261 |
| 150 | CDK5 | 0.12608969 |
| 151 | MAP3K11 | 0.12089034 |
| 152 | RPS6KA1 | 0.12062774 |
| 153 | NME2 | 0.11882625 |
| 154 | OXSR1 | 0.11299596 |
| 155 | PAK1 | 0.11216826 |
| 156 | IGF1R | 0.10553239 |
| 157 | CDC42BPA | 0.09579329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 5.32470165 |
| 2 | Gastric acid secretion_Homo sapiens_hsa04971 | 4.74362113 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.68942233 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 4.24472261 |
| 5 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 4.13613472 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.95983767 |
| 7 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.76372790 |
| 8 | Glutathione metabolism_Homo sapiens_hsa00480 | 3.36659983 |
| 9 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.02695212 |
| 10 | Endometrial cancer_Homo sapiens_hsa05213 | 2.79206131 |
| 11 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 2.56363793 |
| 12 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.47356534 |
| 13 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.37158643 |
| 14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.20965132 |
| 15 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 2.13263042 |
| 16 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.97644225 |
| 17 | Proteasome_Homo sapiens_hsa03050 | 1.96532047 |
| 18 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.93474034 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.85842887 |
| 20 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.82029003 |
| 21 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.78423683 |
| 22 | Hepatitis C_Homo sapiens_hsa05160 | 1.72511640 |
| 23 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.72075521 |
| 24 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.70943584 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.60512357 |
| 26 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.58603856 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.53090251 |
| 28 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.52368689 |
| 29 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.50607057 |
| 30 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.48169590 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48108391 |
| 32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.47310164 |
| 33 | Insulin resistance_Homo sapiens_hsa04931 | 1.40949186 |
| 34 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.39358122 |
| 35 | Mineral absorption_Homo sapiens_hsa04978 | 1.38343535 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.37702538 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.33570723 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31622210 |
| 39 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.28779280 |
| 40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.27523812 |
| 41 | Prostate cancer_Homo sapiens_hsa05215 | 1.26187563 |
| 42 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.24581237 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.23388034 |
| 44 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.23196519 |
| 45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.20441744 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19580353 |
| 47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.17322753 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.11833030 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.10690608 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 1.09817445 |
| 51 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.08461388 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06512483 |
| 53 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.05571308 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04109616 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.01188150 |
| 56 | Ribosome_Homo sapiens_hsa03010 | 1.00435370 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00073395 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98933090 |
| 59 | Base excision repair_Homo sapiens_hsa03410 | 0.98356922 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97463383 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96885069 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96705507 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96367037 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.90912309 |
| 65 | Melanoma_Homo sapiens_hsa05218 | 0.89368480 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 0.89317942 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87270472 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86307959 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85372389 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85151274 |
| 71 | DNA replication_Homo sapiens_hsa03030 | 0.84701567 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82945684 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80072681 |
| 74 | Histidine metabolism_Homo sapiens_hsa00340 | 0.76666588 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76383979 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76056803 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72646050 |
| 78 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.70448121 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69499373 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68696651 |
| 81 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68393193 |
| 82 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67911917 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67355006 |
| 84 | RNA transport_Homo sapiens_hsa03013 | 0.67198364 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65784473 |
| 86 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.65501908 |
| 87 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.64875587 |
| 88 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.61790883 |
| 89 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60627555 |
| 90 | Hepatitis B_Homo sapiens_hsa05161 | 0.60525970 |
| 91 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58726202 |
| 92 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57211434 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57092055 |
| 94 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.54063044 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53725957 |
| 96 | Spliceosome_Homo sapiens_hsa03040 | 0.52411674 |
| 97 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52136556 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52119328 |
| 99 | Tight junction_Homo sapiens_hsa04530 | 0.51188945 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51050570 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51030686 |
| 102 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.49744984 |
| 103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48683096 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46282032 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.45561999 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.45147535 |
| 107 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45115332 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44340727 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44158408 |
| 110 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43555458 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42569144 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42395899 |
| 113 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.42285544 |
| 114 | Alcoholism_Homo sapiens_hsa05034 | 0.42130168 |
| 115 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40681780 |
| 116 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.39724057 |
| 117 | Apoptosis_Homo sapiens_hsa04210 | 0.39458183 |
| 118 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37973662 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.37946354 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37658720 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37359359 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35045199 |
| 123 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.34971103 |
| 124 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33823668 |
| 125 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.32727404 |
| 126 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.32353780 |
| 127 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.31950344 |
| 128 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.31417475 |
| 129 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.31395892 |
| 130 | Lysosome_Homo sapiens_hsa04142 | 0.31084322 |
| 131 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30223325 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30036275 |
| 133 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29193506 |
| 134 | Salivary secretion_Homo sapiens_hsa04970 | 0.28258591 |
| 135 | Peroxisome_Homo sapiens_hsa04146 | 0.26722961 |
| 136 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.22961355 |
| 137 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.21992824 |
| 138 | ABC transporters_Homo sapiens_hsa02010 | 0.21950524 |
| 139 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.21282490 |
| 140 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.20041869 |
| 141 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.19011159 |
| 142 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.18906708 |
| 143 | Adherens junction_Homo sapiens_hsa04520 | 0.17988815 |
| 144 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.14129728 |
| 145 | Bladder cancer_Homo sapiens_hsa05219 | 0.13968359 |
| 146 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.13770675 |
| 147 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.12888839 |
| 148 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.12573869 |
| 149 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.11833270 |
| 150 | Salmonella infection_Homo sapiens_hsa05132 | 0.11715799 |
| 151 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.11094999 |
| 152 | Insulin secretion_Homo sapiens_hsa04911 | 0.10708991 |
| 153 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.09429134 |
| 154 | Metabolic pathways_Homo sapiens_hsa01100 | 0.08393862 |
| 155 | Long-term potentiation_Homo sapiens_hsa04720 | 0.08138938 |
| 156 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.07917873 |
| 157 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.07547400 |
| 158 | Renin secretion_Homo sapiens_hsa04924 | 0.07499658 |
| 159 | Shigellosis_Homo sapiens_hsa05131 | 0.07337048 |
| 160 | Galactose metabolism_Homo sapiens_hsa00052 | 0.07068149 |
| 161 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.06075200 |
| 162 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.05479416 |
| 163 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.05412173 |
| 164 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.04541034 |
| 165 | Focal adhesion_Homo sapiens_hsa04510 | 0.03431114 |

